A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG 162) Meeting Abstract
| Authors: | Spriggs, D. R.; Brady, M.; Rubin, S.; Hanley, M.; Copeland, L. J.; Clarke-Pearson, D.; Burger, R. |
| Abstract Title: | A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG 162) |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 450S |
| Language: | English |
| ACCESSION: | WOS:000223512401783 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.3032 |
| Notes: | Meeting Abstract: 5004 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work